Skip to main content
. 2021 Mar 22;5:26. doi: 10.1038/s41698-021-00160-9

Fig. 6. The model of CXCL12 role in cancer progression.

Fig. 6

Adipose stromal cells (ASC) derived from WAT are the principal source of CXCL12 driving cancer by increasing the survival and proliferation of cancer cells and subsequently their EMT and aggressiveness via CXCR4-mediated signaling. Lightning bolt: D-CAN as a proof-of-principal experimental therapeutic that can be used to deplete ASC and suppress cancer progression.